HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nancy Reau Selected Research

Nancy Reau Research Topics

Disease

20Infections
11/2023 - 07/2006
14Fibrosis (Cirrhosis)
01/2024 - 08/2009
12Hepatitis C
01/2021 - 07/2006
11Chronic Hepatitis C
01/2020 - 07/2006
7Liver Diseases (Liver Disease)
09/2023 - 10/2015
5Non-alcoholic Fatty Liver Disease
01/2024 - 12/2016
4Hepatocellular Carcinoma (Hepatoma)
11/2022 - 08/2009
3Fatigue
09/2022 - 07/2006
2Liver Neoplasms (Liver Cancer)
11/2022 - 01/2021
2Liver Cirrhosis (Hepatic Cirrhosis)
10/2022 - 01/2016
2HIV Infections (HIV Infection)
12/2021 - 08/2009
2Acute Liver Failure (Fulminant Hepatic Failure)
01/2021 - 08/2019
2Substance-Related Disorders (Drug Abuse)
01/2020 - 01/2017
2Hepatitis B
01/2018 - 12/2016
2End Stage Liver Disease
01/2016 - 09/2012
2Ascites
10/2015 - 09/2012
2Anemia
08/2008 - 07/2006
1Fatty Liver
12/2022
1Residual Neoplasm
11/2022
1Hypoxia (Hypoxemia)
11/2022
1Neoplasms (Cancer)
11/2022
1Systemic Mastocytosis
10/2022
1Jaundice (Icterus)
09/2022
1Abdominal Pain (Pain, Abdominal)
09/2022
1Obesity
10/2021
1Kaposi Sarcoma (Kaposi's Sarcoma)
09/2021
1Acquired Immunodeficiency Syndrome (AIDS)
09/2021
1COVID-19
01/2021
1Thrombocytopenia (Thrombopenia)
10/2020
1Hemorrhage
10/2020
1Alcoholism (Alcohol Abuse)
01/2020
1Alcoholic Fatty Liver
01/2020
1Alcoholic Liver Diseases (Alcoholic Liver Disease)
01/2020
1Hepatitis
01/2018
1Chronic Disease (Chronic Diseases)
10/2016
1Hepatic Encephalopathy
01/2016
1Heart Failure
01/2016
1Alcoholic Hepatitis
10/2015
1Brain Diseases (Brain Disorder)
10/2015
1Hemolytic Anemia
08/2008
1Chronic Kidney Failure (Chronic Renal Failure)
07/2006

Drug/Important Bio-Agent (IBA)

13Antiviral Agents (Antivirals)IBA
12/2021 - 01/2013
11Ribavirin (Virazole)FDA LinkGeneric
01/2020 - 07/2006
6InterferonsIBA
10/2018 - 07/2006
5SofosbuvirIBA
10/2018 - 12/2015
4velpatasvirIBA
01/2018 - 12/2015
3RNA (Ribonucleic Acid)IBA
11/2023 - 10/2017
3glecaprevir and pibrentasvirIBA
07/2023 - 01/2018
3AlbuminsIBA
01/2021 - 09/2012
3Proteins (Proteins, Gene)FDA Link
01/2020 - 05/2015
2Transaminases (Aminotransferases)IBA
09/2022 - 01/2021
2grazoprevirIBA
01/2020 - 10/2017
2elbasvirIBA
01/2020 - 10/2017
2Proton Pump InhibitorsIBA
10/2017 - 01/2016
2Protease Inhibitors (Protease Inhibitor)IBA
11/2016 - 05/2015
2N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
01/2013 - 08/2011
2telaprevirIBA
01/2013 - 08/2011
2Hemoglobins (Hemoglobin)IBA
08/2008 - 07/2006
1Immunoglobulin G (IgG)IBA
01/2024
1SteroidsIBA
01/2024
1TerlipressinIBA
09/2023
1tecovirimatIBA
01/2023
13- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA
01/2023
1smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA
01/2023
1Biomarkers (Surrogate Marker)IBA
12/2022
1Carbonic Anhydrase IXIBA
11/2022
1Epithelial Cell Adhesion MoleculeIBA
11/2022
1avapritinibIBA
10/2022
1Thrombopoietin ReceptorsIBA
10/2020
1Acyclovir (Aciclovir)FDA LinkGeneric
08/2019
1sofosbuvir velpatasvir voxilaprevir drug combinationIBA
01/2018
1voxilaprevirIBA
11/2016
1NucleotidesIBA
11/2016
1Reducing AgentsIBA
01/2016
1AcidsIBA
01/2016
1ElectrolytesIBA
01/2016
1ZincIBA
10/2015
1DiureticsIBA
10/2015
1BilirubinIBA
10/2015
18- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA
05/2015
1asunaprevirIBA
05/2015
1daclatasvirIBA
05/2015
1Interferon-alpha (Interferon Alfa)IBA
01/2013
1peginterferon alfa-2a (Pegasys)FDA Link
08/2008
1Aligeron (AS 2)IBA
07/2006

Therapy/Procedure

16Therapeutics
01/2024 - 08/2009
9Liver Transplantation
01/2024 - 12/2016
1Drug Therapy (Chemotherapy)
12/2022
1Highly Active Antiretroviral Therapy (HAART)
09/2021
1Platelet Transfusion (Blood Platelet Transfusions)
10/2020
1Aftercare (After-Treatment)
10/2016
1Patient Readmission
01/2016
1Duration of Therapy
11/2015
1Transplantation
08/2009